Feature | April 15, 2011

Support Programs Aid Women With Heart Disease

WomenHeart is the only national organization dedicated to promoting women’s heart health through advocacy, education and patient support. As the leading voice for the 42 million American women living with or at risk of heart disease, WomenHeart advocates for equal access to quality care and provides information and resources to help women take charge of their heart health.

Lise Tate, CAE, CEO of WomenHeart, the National Coalition for Women With Heart Disease, said the nonprofit group helps set up hospital support groups to guide women through their treatment and recovery. Since its inception, WomenHeart – founded by three women heart attack survivors who transformed the isolation, confusion and ignorance about women’s heart disease into a rallying call to save women’s lives — has been at the forefront of providing support services to women with heart disease and educating policymakers, health professionals and the public about the urgent need to make women’s heart health a priority.

Founded in 1999, WomenHeart’s mission is to improve the health and quality of life of women living with or at risk of heart disease. Through our programs and services, WomenHeart raises awareness about the importance of prevention and early detection, accurate diagnosis and proper treatment of women’s heart disease.

WomenHeart is a coalition and a community of thousands of members nationwide, including women heart patients and their families, physicians, health advocates and consumers committed to helping women live longer, healthier lives. At the center of the organization are the more than 500 WomenHeart Champions, all heart disease survivors, who have graduated from WomenHeart’s Science and Leadership Symposium at the Mayo Clinic. These alumnae serve as WomenHeart local support group leaders, community educators, media spokeswomen, and general support volunteers.

Through leadership and advocacy training, information resources and an online community, WomenHeart empowers women living with heart disease to manage their own heart health and to help all women take charge of their heart health. For more information: www.womenheart.org

Related Content

First European Patient Enrolled in Intact Vascular's TOBA II BTK Trial
News | Stents Peripheral| July 26, 2017
Intact Vascular Inc. recently announced that its Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK)...
First Patient Treated in U.S. Feasibility Study of LimFlow Critical Limb Ischemia Device
News | Peripheral Arterial Disease (PAD)| July 17, 2017
LimFlow SA announced enrollment of the first patient in the U.S. feasibility study of the LimFlow Percutaneous Deep...
FDA Approves Six-Month Primary Endpoint for Tack Endovascular System in Below the Knee Disease
News | Stents Peripheral| July 14, 2017
Intact Vascular Inc. announced the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption...
Edwards Sapien 3 TAVR valve will be implanted in asymptomatic aortic stenosis patients in the EARLY TAVR Trial
Feature | Heart Valve Technology| July 14, 2017
July 14, 2017 — Morristown Medical Center, part of Atlantic Health System, has randomized the first patient in the wo
long-duration dual anti-platelet therapy (L-DAPT) compared to short-duration dual antiplatelet (S-DAPT) after DES stent implantation
News | Antiplatelet and Anticoagulation Therapies| July 12, 2017
June 12, 2017 — Researchers have evaluated the long-term efficacy and safety of long-duration dual anti-platelet ther
Medtronic's CoreValve Evolut R gained FDA approval for intermediate risk patients

An illustration of the self-expanding CoreValve Evolut R TAVR valve half deployed in the aortic root.

Feature | Heart Valve Technology| July 10, 2017
The U.S. Food and Drug Administration (FDA) has cleared an additional indication to expand the use Medtronic's self-...
Patient Race, Gender Both Important in Predicting Heart Attack Symptoms in the ER
News | Cath Lab| July 07, 2017
Researchers at the George Washington University (GW) found that certain symptoms are more and less predictive of...
ACCESS PTS Study Demonstrates Efficacy of EKOS Therapy for Post-Thrombotic Syndrome
News | Deep Vein Thrombosis| July 07, 2017
BTG plc recently highlighted the results of the ACCESS PTS trial, presented at the Society for Vascular Medicine 28th...
Sex-Specific Cardiovascular Drug Dosages Needed to Reduce Adverse Reactions in Women
News | Womens Healthcare| July 07, 2017
Sex-specific cardiovascular drug dosages are needed to reduce adverse reactions in women, according to a position paper...
Greater Emphasis Needed on Preventing, Treating Heart Disease in Women
News | Womens Healthcare| July 06, 2017
Women and physicians do not put enough emphasis on cardiovascular disease in women, and a social stigma regarding body...
Overlay Init